World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
74
Citations
18110
World Ranking
19463
National Ranking
9690

Research.com Recognitions

  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

Matthew D. Ringel is affiliated with The Ohio State University in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics, and Molecular Biology, with a focus on endocrine-related diseases and molecular mechanisms.

The main areas of study include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, their work further specializes in subfields such as:

  • Endocrinology, Diabetes and Metabolism
  • Molecular Biology
  • Genetics
  • Surgery
  • Oncology

The scientist's research topics cover:

  • Thyroid Cancer Diagnosis and Treatment
  • BRCA gene mutations in cancer
  • Cancer-related Molecular Pathways
  • Thyroid and Parathyroid Surgery
  • S100 Proteins and Annexins
  • Genetic Associations and Epidemiology
  • Cancer, Hypoxia, and Metabolism

Frequent publication venues reflect a concentration in endocrinology and oncology journals:

  • Thyroid
  • Journal of the Endocrine Society
  • The Journal of Clinical Endocrinology & Metabolism
  • Cancer Research
  • Endocrine Related Cancer

Matthew D. Ringel has collaborated regularly with several co-authors, including:

  • Sandya Liyanarachchi
  • Pamela Brock
  • Fadi Nabhan
  • Jennifer A. Sipos
  • Neel Rajan

Some representative recent publications by the scientist include:

  • Thyroid cancer, recent advances in diagnosis and therapy, 2021, International Journal of Cancer
  • GWAS of thyroid stimulating hormone highlights pleiotropic effects and inverse association with thyroid cancer, 2020, Nature Communications
  • Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review, 2022, Thyroid
  • American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment, 2022, Head & Neck
  • Dabrafenib Versus Dabrafenib + Trametinib in BRAF -Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer: Results of a Randomized, Phase 2, Open-Label Multicenter Trial, 2022, Thyroid

Among recognitions received, Matthew D. Ringel is noted as a member of the Association of American Physicians.

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • Medullary thyroid cancer: management guidelines of the American Thyroid Association.

    Richard T. Kloos;Charis Eng;Douglas B. Evans;Gary L. Francis

  • BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

    Mingzhao Xing;William H. Westra;Ralph P. Tufano;Yoram Cohen

  • Phase II Trial of Sorafenib in Metastatic Thyroid Cancer

    Richard T. Kloos;Matthew D. Ringel;Michael V. Knopp;Nathan C. Hall

  • Phase II Clinical Trial of Sorafenib in Metastatic Medullary Thyroid Cancer

    Elaine T. Lam;Matthew D. Ringel;Richard T. Kloos;Thomas W. Prior

  • Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion

    Vasily Vasko;Allan V. Espinosa;William Scouten;Huiling He

  • Overexpression and Overactivation of Akt in Thyroid Carcinoma

    Matthew D. Ringel;Nicole Hayre;Jun Saito;Bertrand Saunier

  • Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.

    David L. Steward;Sally E. Carty;Rebecca S. Sippel;Samantha Peiling Yang

  • Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer

    Krystian Jazdzewski;Sandya Liyanarachchi;Michal Swierniak;Janusz Pachucki

  • Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia.

    Swarnali Acharyya;Matthew E.R. Butchbach;Zarife Sahenk;Huating Wang

  • Multi-Institutional Phase II Study of Selumetinib in Patients With Metastatic Biliary Cancers

    Tanios Bekaii-Saab;Mitch A. Phelps;Xiaobai Li;Motoyasu Saji

  • NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018

    Robert I. Haddad;Christian Nasr;Lindsay Bischoff;Naifa Lamki Busaidy

  • Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer

    V Vasko;M Saji;E Hardy;M Kruhlak

  • Discovery of common variants associated with low TSH levels and thyroid cancer risk

    Julius Gudmundsson;Patrick Sulem;Daniel F Gudbjartsson;Jon G Jonasson

  • Metastin Receptor Is Overexpressed in Papillary Thyroid Cancer and Activates MAP Kinase in Thyroid Cancer Cells

    Matthew D. Ringel;Elena Hardy;Victor J. Bernet;Henry B. Burch

  • The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.

    Motoyasu Saji;Matthew D. Ringel

  • Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma.

    Jennifer A. Woyach;Richard T. Kloos;Matthew D. Ringel;Daria Arbogast

  • Clinical implications of genetic defects in G proteins. The molecular basis of McCune-Albright syndrome and Albright hereditary osteodystrophy.

    Matthew D. Ringel;William F. Schwindinger;Michael A. Levine

  • Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy?

    Herbert Chen;Theresa L. Nicol;Martha A. Zeiger;William C. Dooley

Frequent Co-Authors

Kenneth D. Burman
Kenneth D. Burman MedStar Washington Hospital Center
Albert de la Chapelle
Albert de la Chapelle The Ohio State University
Sandya Liyanarachchi
Sandya Liyanarachchi The Ohio State University
Michael A. Levine
Michael A. Levine Children's Hospital of Philadelphia
Charis Eng
Charis Eng Cleveland Clinic Lerner College of Medicine
Kari Stefansson
Kari Stefansson deCODE Genetics (Iceland)
Leonard Wartofsky
Leonard Wartofsky MedStar Washington Hospital Center
Ching-Shih Chen
Ching-Shih Chen The Ohio State University
R. Michael Tuttle
R. Michael Tuttle Memorial Sloan Kettering Cancer Center
Michael C. Ostrowski
Michael C. Ostrowski Medical University of South Carolina

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring Medicine in the USA, there are several alternative pathways and related healthcare degrees you can pursue online. For those with a bachelor’s degree in a non-nursing major, direct entry msn programs for non-nurses online offer a fast-track option to becoming a nurse, combining graduate-level education with foundational nursing coursework.

Some prospective nurses seek admissions with fewer hurdles. Looking for the easiest bsn program to get into can help you start your nursing journey without high barriers such as low acceptance rates or intense prerequisites. Additionally, finding a nursing school that does not require teas test can further simplify the application process, removing a common standardized testing requirement.

If you’re interested in healthcare administration without direct patient care, training through medical billing and coding schools with financial aid is a flexible choice that’s in high demand. Each pathway and specialty has its own requirements and advantages, so carefully consider your interests, academic background, and career goals when making a choice.

Best Scientists Citing Matthew D. Ringel

Trending Scientists